Momenta, Novartis, Sanofi fall on Lovenox suit

Legal News Updates Posted on

Shares of partners Momenta Pharmaceuticals and Novartis AG moved notably lower early Tuesday, the day after rival Sanofi-Aventis filed a federal lawsuit to prevent the companies from launching a generic version of Sanofi's blockbuster drug Lovenox.

The U.S. Food and Drug Administration, which was also named in the suit, approved a generic version of the blood-thinner last Friday. Sanofi's suit is seeking to have the approval rescinded.

In a statement, Momenta said that the court will hold a hearing on Aug. 17 to consider a temporary injunction against the generic product. The company added that the court has not placed any sales restrictions on the product in the meantime.

Legal News Media

Legal News Organization press is the top headline legal news provider for lawyers and legalprofessionals. Read law articles and breaking news from law firm's across the United States to get the latest updates. The content contained on the web site has been prepared by Legal News Media as a service to the internet
community and is not intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.

 

www.legal-news.org

 

American Bar Association – Start and Run a Law Firm

NewYorkStateBar.com – Starting a Law Firm

Lawyer Web Direct

CPA Website Designs